- Tue Sep 21, 2021 1:22 pm
#100754
Complete Question Explanation
Weaken. The correct answer choice is (A).
The consumer advocate begins the argument by observing the possibility of harm that can come from drug-related interactions, using the example of aspirin's interaction with fruit juice and the harm it can cause of unnecessary discomfort or taking too much aspirin. Based on the observation and example, the advocate makes a rather sweeping conclusion that the government should require drug companies to disclose to consumers every known drug-related interaction.
While the advocate's argument envisions a potential benefit of disclosing drug interactions (making consumers aware of problematic interactions), it does not tell us whether there might be downsides of such a requirement. This is a major problem for the argument.
The question stem asks for an answer that most weakens the advocate's argument. Focus on the problem we've identified in the argument: let's look for an answer that brings up any downsides of requiring the government to disclose every known drug interaction to consumers. In other words, look for an answer that could suggest the opposite of the conclusion, i.e. that could show that maybe the government should not require the disclosure of every drug interaction.
Answer choice (A): This is the correct answer choice. Answer choice A raises a downside of the proposed conclusion, by suggesting that it might cause consumers to forget about or ignore serious drug interactions. This would suggest that the government should perhaps not go as far as the conclusion wants to go, i.e. that the government should not necessarily disclose every known drug interaction.
Answer choice (B): Answer choice B has no impact on the conclusion, because it does not give any guidance as to whether the interactions it mentions should or should not be disclosed to consumers.
Answer choice (C): Since answer choice C does not provide a significant downside to the disclosures (price increases would be negligible), it does not provide a reason the government should not make the recommended disclosures. Thus, it does not weaken the conclusion.
Answer choice (D): Answer choice D is irrelevant, because the conclusion is limited to the question of whether to disclose the drug interactions we know about (notice the conclusion's language, requiring notification of "all known drug-related interactions").
Answer choice (E): Answer choice E is irrelevant, because what pharmacists usually do does not tell us whether there could be some benefit from doing something different or more than what they usually do. Thus, answer choice E does not weaken the conclusion.
Weaken. The correct answer choice is (A).
The consumer advocate begins the argument by observing the possibility of harm that can come from drug-related interactions, using the example of aspirin's interaction with fruit juice and the harm it can cause of unnecessary discomfort or taking too much aspirin. Based on the observation and example, the advocate makes a rather sweeping conclusion that the government should require drug companies to disclose to consumers every known drug-related interaction.
While the advocate's argument envisions a potential benefit of disclosing drug interactions (making consumers aware of problematic interactions), it does not tell us whether there might be downsides of such a requirement. This is a major problem for the argument.
The question stem asks for an answer that most weakens the advocate's argument. Focus on the problem we've identified in the argument: let's look for an answer that brings up any downsides of requiring the government to disclose every known drug interaction to consumers. In other words, look for an answer that could suggest the opposite of the conclusion, i.e. that could show that maybe the government should not require the disclosure of every drug interaction.
Answer choice (A): This is the correct answer choice. Answer choice A raises a downside of the proposed conclusion, by suggesting that it might cause consumers to forget about or ignore serious drug interactions. This would suggest that the government should perhaps not go as far as the conclusion wants to go, i.e. that the government should not necessarily disclose every known drug interaction.
Answer choice (B): Answer choice B has no impact on the conclusion, because it does not give any guidance as to whether the interactions it mentions should or should not be disclosed to consumers.
Answer choice (C): Since answer choice C does not provide a significant downside to the disclosures (price increases would be negligible), it does not provide a reason the government should not make the recommended disclosures. Thus, it does not weaken the conclusion.
Answer choice (D): Answer choice D is irrelevant, because the conclusion is limited to the question of whether to disclose the drug interactions we know about (notice the conclusion's language, requiring notification of "all known drug-related interactions").
Answer choice (E): Answer choice E is irrelevant, because what pharmacists usually do does not tell us whether there could be some benefit from doing something different or more than what they usually do. Thus, answer choice E does not weaken the conclusion.
Jeremy Press
LSAT Instructor and law school admissions consultant
Follow me on Twitter at: https://twitter.com/JeremyLSAT
LSAT Instructor and law school admissions consultant
Follow me on Twitter at: https://twitter.com/JeremyLSAT